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ORIGINAL ARTICLE

Temporal Evolution of the PcvCO2–PaCO2/CaO2–CcvO2
Ratio vs Serum Lactate during Resuscitation in Septic Shock
Shyam Madabhushi1 , Anjan Trikha2 , Rahul K Anand3 , Rashmi Ramachandran4 , Preet M Singh5 , Vimi Rewari6

A b s t r ac t
Background: Lactate as a target for resuscitation in patients with septic shock has important limitations. The PcvCO2–PaCO2/CaO2–CcvO2
ratio may be used as an alternative for the same. The primary outcome of the study is to evaluate the correlation between serum lactate and
PcvCO2–PaCO2/CaO2–CcvO2 ratio measured at various time points to a maximum of 24 hours in patients with septic shock [mean arterial pressure
(MAP) <65 mm Hg]. The secondary outcomes were to study the (1) relationship between the PcvCO2–PaCO2/CaO2–CcvO2 ratio and lactate
clearance at 6, 12, and 24 hours as compared to the initial serum lactate, (2) to ascertain whether the PcvCO2–PaCO2/CaO2–CcvO2 ratio and the
arterial lactate levels in the first 24 hours are able to predict mortality at day 28 of enrollment, and (3) to determine whether the PcvCO2–PaCO2/
CaO2–CcvO2 ratio and arterial lactate are useful in discriminating survivors from nonsurvivors.
Materials and methods: Thirty patients with sepsis-induced hypotension who were being actively resuscitated were enrolled. Paired arterial
and central venous blood samples were obtained 0.5 hourly till stabilization of MAP and 6 hourly thereafter for the first 24 hours. Patients were
followed up to day 28 of enrollment for mortality and organ system failure.
Results: A positive correlation was observed between arterial lactate and PcvCO2–PaCO2/CaO2–CcvO2 ratio at 0, 6, 12, and 18 hours (R = 0.413,
p = 0.02; R = 0.567, p = 0.001; R = 0.408, p = 0.025; R = 0.521, p = 0.003, respectively). No correlation was seen between PcvCO2–PaCO2/CaO2–
CcvO2 ratio and lactate clearance. The subgroup analysis showed that PcvCO2–PaCO2/CaO2–CcvO2 ratio >1.696 at 24 hours of resuscitation
predicted 28-day mortality (sensitivity: 80%, specificity 69.2%, area under the receiver operating characteristic curve 0.82).
Conclusion: The PcvCO2–PaCO2/CaO2–CcvO2 ratio and lactate are positively correlated during the first 24 hours of active resuscitation from
sepsis-induced hypotension, and a threshold of 1.696 mm Hg/mL/dL at 24 hours significantly differentiates survivors from nonsurvivors
(CTRI/2017/11/010342).
Keywords: PcvCO2–PaCO2/CaO2–CcvO2 ratio, Resuscitation, Septic shock, Serum lactate.
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Introduction

1

Sepsis has been defined as a dysregulated host response to
infection.1 Patients with sepsis are frequently admitted to the
intensive care unit (ICU) for managing hypotension and are
resuscitated with vasopressors and intravenous crystalloids. The
Surviving Sepsis Campaign2 recommends resuscitation end points,
which may be classified as macro- or microcirculatory. 3 Arterial
lactate, a commonly used end point, is considered an imperfect
marker of anaerobic metabolism in sepsis.4 As an alternative, the
PcvCO2–PaCO2/CaO2–CcvO2 ratio has been proposed. The shock
causes a decrease in tissue perfusion and oxygen availability,
which shifts energy production to anaerobic pathways, leading to a
decrease in the ratio of aerobic to anaerobic metabolism. To detect
this shift, the ratio of CO2 production and O2 utilization is measured.
In a perfectly aerobic system, all CO2 production is derived from
aerobic glucose oxidation, which leads to a CO2 production: O2
utilization ratio of 1.0. If anaerobic metabolism increases, the O2
utilization reduces but the anaerobic production of CO2 continues,
thereby resulting in an increase in the CO2 production: O2 utilization
ratio. Since the measurement of the actual CO2 production and
O2 utilization is not practical in the clinical setting, the PcvCO2–
PaCO2/CaCO2–CcvO2 ratio is used as a surrogate of the same. The
numerator reflects CO2 production, whereas the denominator
reflects O2 utilization. In shock, the ratio is expected to increase,
implying worsening tissue hypoxia. Resuscitation would improve O2
utilization, which would result in a reduction of the ratio. This ratio
may be alternatively called the “calculated respiratory quotient.”

Previous studies that have investigated the utility of the
PcvCO2–PaCO2 /CaO2–CcvO2 ratio have important limitations.
Some were retrospective in nature5 or included patients after
attaining resuscitation end points as defined by the Surviving Sepsis
Campaign guidelines.6 Our study, therefore, is aimed at delineating
the evolution of the PcvCO2–PaCO2 /CaO2–CcvO2 ratio during
the first 24 hours of resuscitation in patients with sepsis-induced
hypotension and contrast it with the evolution of arterial lactate.
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Aims

and

Objectives

The primary objective of the study is to examine the correlation
between the PcvCO2–PaCO2/CaO2–CcvO2 ratio and the arterial
lactate during the first 24 hours of resuscitation from septic shock.
The secondary objectives of the study are: (1) to examine the
correlation between the PcvCO2–PaCO2/CaO2–CcvO2 ratio and
the lactate clearance within the same time period, (2) to ascertain
whether the PcvCO2–PaCO2/CaO2–CcvO2 ratio and the arterial
lactate levels in the first 24 hours are able to predict mortality at day
28 of enrollment, and (3) to determine whether the PcvCO2–PaCO2/
CaO2–CcvO2 ratio and arterial lactate are useful in discriminating
survivors from nonsurvivors. A subgroup analysis (survivors and
nonsurvivors at day 28 of enrollment) of the PcvCO2–PaCO2/CaO2–
CcvO2 ratio and the arterial lactate was also planned.

M at e r ia l s

and

Methods

PaCO2/CaO2–CcvO2 ratio. Two sampling intervals were followed.
To capture the early phase of resuscitation, initially, these paired
samples were drawn and analyzed at half-hourly intervals till
stable MAP targets were achieved. Stability was defined as
MAP >65 mm Hg for more than 15 minutes without escalating
the doses of vasopressors. A maximum of four such samples was
permitted (accounting for the first 2 hours). For the remainder
of the first 24 hours, sampling and measurement were done
six hourly. Data were entered into a standard format. Clinical
decision-making and interventions were as per the intensivist in
charge of the case. Hemoglobin levels were obtained from the
central laboratory. The following were calculated according to
standard formulae:
•
•

Patients
A prospective observational study was designed and conducted
in two ICUs of a tertiary care hospital in North India. One is
a 10-bedded mixed medical–surgical ICU and the other is a
12-bedded level-3 trauma ICU. Patients were recruited from
September 2016 to June 2018. All adult patients admitted to the
ICU with sepsis-induced hypotension [defined as mean arterial
pressure (MAP) <65 mm Hg] and with an arterial and central venous
catheter were considered for inclusion into the study. Pregnancy,
patients less than 18 years of age, those who did not have a central
or arterial line inserted, those in whom resuscitation was aimed
at supraphysiological targets, and those in whom consent was
not available were excluded from the study. Flowchart 1 depicts
the procedure of enrollment of patients in the study. The trial was
approved by the institutional ethics committee and was registered
with the Clinical Trials Registry of India (CTRI/2017/11/010342).

Measurements
Paired arterial and central venous samples were drawn from
enrolled patients to measure lactate and calculate the PcvCO2–

•

A r te r i a l ox yg e n co nte nt (C a O 2 ): C a O 2 (m L O 2 /d L)
= (1.34 × hemoglobin concentration × SaO2) + (0.0031 × PaO2)
Central venous oxygen content (CcvO2): CcvO2 (mL O2 /dL)
= (1.34 × hemoglobin concentration × ScvO2) + (0.0031 × PaO2)
Lactate clearance at 6, 12, 18, and 24 hours using arterial lactate
at enrollment as baseline (lactate T0). Lactate clearance (using
6 hours as an example): (arterial lactate at T0 - arterial lactate at
6 hours)/arterial lactate at T0 × 100%

All patients were followed up for 28 days after enrollment or
death or hospital discharge (whichever was earlier).
To calculate the sample size, data from a study by MekontsoDessap et al. 5 were used. The correlation bet ween the
PcvCO2–PaCO2 /CaO2–CcvO2 ratio and the lactate was 0.57.
Using a two-tailed type-I error of 0.05 and a type-II error of 0.2,
a sample size of 22 was obtained. We enrolled 30 patients in our
study.

Statistical Analysis
Patient characteristics and demographic data were described in
terms of mean and standard deviation (SD) or median and range,
as applicable. Correlation between the PcvCO2–PaCO2/CaO2–CcvO2
ratio and lactate and PcvCO2–PaCO2/CaO2–CcvO2 ratio and lactate
clearance were calculated using the Spearman’s coefficient ( p).

Flowchart 1: Study flow diagram
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Subgroup analysis of these variables between survivors and
nonsurvivors was done using the Wilcoxon–Mann–Whitney test.
Sensitivity and specificity of the PcvCO2–PaCO2/CaO2–CcvO2 ratio
and lactate for predicting mortality were calculated, and receiver
operating characteristic (ROC) curves were constructed. To analyze
whether the proportion of patients with calculated thresholds for
lactate and the PcvCO2–PaCO2/CaO2–CcvO2 ratio were different
between survivors and nonsurvivors, the Fisher’s exact test was
used. A p value of <0.05 was considered statistically significant. All
statistical analyses were performed using Stata (Ver 15.1; StataCorp
LLC, Texas, USA).

R e s u lts
Data from all 30 patients were analyzed which included a total of 186
samples. Two patients died in the 18–24 hours’ period. Their data
till the 18-hour mark were collected and analyzed. Eight patients
were sampled half-hourly beyond the first half hour. The rest of the
patients had a stable MAP at the end of the first half hour and did
not need additional half-hourly sampling.
The mean age of the patients was 38 years (SD 17.54; range
18–77 years). The median time between hospital admission and the
development of septic shock was 97 hours (range: 2–1116 hours).
The median time between the identification of hypotension and
the first paired arterial and central venous sample was 0.5 hours
(SD 0.298, range 0–1 hours) (Table 1). The main source (suspected
or proven) of sepsis was respiratory (n = 15; 50%), followed by the
abdomen (n = 8; 26.67%). The source of sepsis remained unknown
in two patients. The median length of ICU stay was 15.5 days.

Thirteen patients survived to day 28 of enrollment (28-day mortality
was 56.6%).
The primary outcome of the study was the correlation
between the PcvCO2–PaCO2/CaO2–CcvO2 ratio and the arterial
lactate at each of the sampling time points. The correlation
between the PcvCO2–PaCO2/CaO2–CcvO2 ratio and the arterial
lactate was positive and was statistically significant at time
points 0, 6, 12, and 18 hours. The correlation was strongest at the
18-hour time point (Table 2). The correlation between the PcvCO2–
PaCO2/CaO2–CcvO2 ratio and the lactate clearance was negative
but reached significance only at one time point (T = 18 hours;
p = −0.4448, p = 0.0138) (Table 3).
The study population was divided into survivors and
nonsurvivors, and data were analyzed to discern differences, if
any, in the parameters assessed. There was no difference in the
mean values of hemoglobin and ScvO2 between the survivors
and nonsurvivors (p >0.05). The PcvCO2–PaCO2/CaO2–CcvO2 ratio
was higher in nonsurvivors than in survivors at all time points
except at 1 hour. However, the difference reached a statistical
significance only at 24 hours (z = −2.879; p = 0.0040) (Table 4).
Assuming that the PcvCO2–PaCO2/CaO2–CcvO2 ratio remained
constant between two measurements, the time duration for
which it remained abnormal (>1) was calculated for differences
between survivors and nonsurvivors. No such difference was
found (Student’s t test, p >0.05). Similar calculations were made
for the arterial lactate between survivors and nonsurvivors
(Table 5). The median lactate was greater in nonsurvivors than in
survivors, but the difference reached significance only at 18 and
24 hours. There was no difference between the time duration for

Table 1: Demographic and disease characteristics
Variable
Age (in years)
Height (in cm)
Weight (in kg)
Time between clinical event and
hospital arrival (in hours)
Time between hospital admission
and development of septic shock (in
hours)
Time between identification of
hypotension and first paired sample
(in hours)
APACHE II score
SOFA at enrollment
Hemoglobin (g/dL)
ScvO2 (%)

Mean
38.4
   165.8 cm
64.9

Median

38

Maximum
77
178
85
720

97

1116

2

0.298

1

0

  1.663
10.26

42
19
14.3
89.1

7
4
6.5
51

0.5

SD
17.54
  6.664
10.24

20.5
10
9.0
73.1

Table 2: Correlation between PcvCO2–PaCO2/CaCO2–CcvO2 ratio and
lactate
Time point
0 hour (enrollment)
0.5 hour
1 hour
6 hours
12 hours
18 hours
24 hours

1372

Spearman’s rho (ρ)
0.4137
0.1908
0.4072
0.5671
0.4085
0.5216
0.3392
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Probability (p) value
0.0231
0.3126
0.3167
0.0011
0.0250
0.0031
0.0774

Minimum
18
155
40
0
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Table 3: Correlation between the PcvCO2–PaCO2/CaO2–CcvO2 ratio and
the lactate clearance
Time point
0.5 hour
1 hour
6 hours
12 hours
18 hours
24 hours

Spearman’s rho (ρ)
0.0980
−0.4286
−0.2511
−0.1427
−0.4448
−0.2370

Probability value (p)
0.6065
0.2894
0.1889
0.4520
0.0138
0.2246

Table 4: PcvCO2–PaCO2/CaO2–CcvO2 ratio in survivors and nonsurvivors
Time point
0
0.5 hour
1 hour
6 hours
12 hours
18 hours
24 hours

Wilcoxon rank sum
−0.984
−1.611
0.745
0.314
−1.235
−1.569
−2.879

Probability value (p)
0.3253
0.1071
0.4561
0.7536
0.2170
0.1165
0.0040

Fig. 1: Receiver operating characteristic curve for PcvCO2–PaCO2/CaO2–
CcvO2 ratio at 24 hours for predicting 28-day mortality

Table 5: Arterial lactate in survivors and nonsurvivors
Time point
0
0.5 hour
1 hour
6 hours
12 hours
18 hours
24 hours

Wilcoxon rank sum
−1.027
−1.027
−1.050
−1.634
−1.848
−2.556
−3.182

Probability value (p)
0.3043
0.3044
0.2938
0.1022
0.0646
0.0106
0.0015

which lactate was elevated (>2 mmol/L) among survivors and
nonsurvivors (p >0.05).
ROCs were constructed after calculating the thresholds for
variables predictive of 28-day mortality. The variables considered
were arterial lactate, venoarterial PCO2 gap, PcvCO2–PaCO2/CaO2–
CcvO2 ratio, ScvO2, and arteriovenous O2 content difference. Of
these variables, only the arterial lactate and the PcvCO2–PaCO2/
CaO2–CcvO2 ratio had a significant area under the ROC curve
(AU-ROC). The PcvCO2–PaCO2/CaO2–CcvO2 ratio at 24 hours with a
value greater than 1.696 mm Hg/mL/dL was predictive of mortality
with a sensitivity of 80% and a specificity of 69.2%. The AU-ROC was
0.8205 (95% confidence interval [CI] 0.661–0.979) (Fig. 1). For arterial
lactate at 24 hours, a value >1.6 mmol/L was predictive of mortality
at 28 days with a sensitivity of 73.33% and a specificity of 69.23%.
The AU-ROC was 0.853 (95% CI 0.712–0.915) (Fig. 2).
Using the log-rank test, survival differences were estimated for
threshold values of both the arterial lactate and PcvCO2–PaCO2/
CaO2–CcvO2 ratio. At time 0, the thresholds chosen were the
normal values of the variables [1 for PcvCO2–PaCO2/CaO2–CcvO2
ratio and 2 mmol/L for arterial lactate]. At the 24-hour time point,
the thresholds chosen were those that were estimated to have the
best sensitivity and specificity for mortality prediction from the ROC
curves. Accordingly, these values were 1.696 for the PcvCO2–PaCO2/
CaO2–CcvO2 ratio and 1.6 mmol/L for the arterial lactate. For the
thresholds chosen at enrollment, there were no differences in the

Fig. 2: Receiver operating characteristic curve for arterial lactate at
24 hours for predicting 28-day mortality

Kaplan–Meier survival estimates [χ2 = 0.70, p = 0.4016 for lactate
2 mmol/L; χ2 = 0.69, p = 0.4076 for PcvCO2–PaCO2/CaO2–CcvO2
ratio]. For the thresholds chosen at time point 24 hours, there were
significant differences in the Kaplan–Meier survival estimates. For
a lactate of 1.6 mmol/L, the probability of 28-day survival was 26.6
and 69.2% above and below this threshold, respectively (χ2 = 5.62,
p = 0.0177) (Fig. 3). For the PcvCO2–PaCO2/CaO2–CcvO2 ratio of
1.696, the probability of 28-day survival was 25 and 75% above and
below this ratio, respectively (χ2 = 6.00, p = 0.0143) (Fig. 4).

Discussion
Our results demonstrated a significant positive correlation
between lactate and the (PcvCO2–PaCO2/CaO2–CcvO2 ratio at 0,
6, 12, and 18 hours during the first 24 hours of resuscitation after
sepsis-induced hypotension. Resuscitation attempts to increase
DO2, which then increases VO2 causing lactate levels to fall.
Simultaneously, the anaerobic production of CO2 decreases, and
the PcvCO2–PaCO2/CaO2–CcvO2 ratio falls. This physiology explains
the positive correlation between these two variables. To the best of
our knowledge, this is probably the only prospective study that has

Indian Journal of Critical Care Medicine, Volume 25 Issue 12 (December 2021)

1373

PcvCO2–PaCO2/CaO2–CcvO2 Ratio vs Arterial Lactate in Sepsis

Fig. 3: Kaplan–Meier survival estimate for lactate >1.6 mmol/L at
24 hours

Fig. 4: Kaplan–Meier survival estimate for PcvCO2–PaCO2/CaCO2–CcvO2
ratio >1.696 mm Hg/mL at 24 hours

looked at stepwise lactate and the PcvCO2–PaCO2/CaO2–CcvO2 ratio
kinetics and studied correlation at each time point with predefined
sampling intervals.
There was a significant negative correlation between the
lactate clearance and the PcvCO2–PaCO2/CaO2–CcvO2 ratio at only
one time point (18 hours; p = −0.4448, p = 0.0138). This is probably
because patients were resuscitated early during sepsis-induced
hypotension, and therefore, the lactate levels were not severely
elevated. The median lactate at enrollment was 1.8 mmol/L, and
the median lactate at the end of 24 hours was 1.65 mmol/L. Only
14 of the 30 patients (47%) had a serum lactate >2.0 mmol/L at
enrollment. Therefore, the overall scope for lactate reduction in
the study population was rather low.
Mekontso-Dessap et al. 5 in their retrospective study on ICU
patients divided them into those with a high (>2.0 mmol/L) and low
lactate (<2.0 mmol/L). They too found good correlation between
the PcvCO2–PaCO2/CaO2–CcvO2) ratio and the lactate (R = 0.57,
p <0.0001). However, the time intervals of these measurements were
not clearly defined. Mesquida et al.6 in their retrospective analysis
of 35 patients explored the ability of the PcvCO2–PaCO2 gap and
1374

PcvCO2–PaCO2/CaO2–CcvO2 ratio to predict the evolution of lactate.
Their patient population included those that had normalized their
ScvO2 and MAP. Their study showed correlation between the
initial lactate and the PcvCO2–PaCO2/CaO2–CcvO2 ratio (R = 0.73,
p <0.001). Although this correlation is higher than the correlation
obtained in our study, this could be due to the fact that samples
were obtained only after normalization of ScvO2 and MAP.
In terms of secondary outcomes, both the PcvCO2–PaCO2/
CaO2–CcvO2 ratio and the arterial lactate are predictive of mortality.
For this, Kaplan–Meier curves were calculated at two points: at
enrollment and at 24 hours. The enrollment curves were constructed
to determine if there was any survival difference at day 28 for
lactate >2 mmol//L and <2 mmol/L. Similarly, the threshold chosen
for the PcvCO2–PaCO2/CaO2–CcvO2 ratio was >1 mm Hg/mL/dL
and <1 mm Hg/mL/dL. Both these thresholds were chosen as the
upper limit of normal values for the lactate and the PcvCO2–PaCO2/
CaO2–CcvO2 ratio. There was no difference in the survival probability
at enrollment for both the variables chosen. This is physiologically
explicable again from the observation that the median lactate at
enrollment in the study was below this threshold (1.8 mmol/L). The
median PcvCO2–PaCO2/CaO2–CcvO2 ratio at enrollment was 1.759.
Although this value was higher than 1.0, in the analysis between
survivors and nonsurvivors, the median value of the PcvCO2–PaCO2/
CaO2–CcvO2 ratio at enrollment was not different between the
two subgroups. The Kaplan–Meier survival curves at 24 hours
were constructed using the thresholds with the best combination
of sensitivity and specificity obtained from the ROC tables. It is
also notable that the largest differences between survivors and
nonsurvivors in terms of the PcvCO2–PaCO2/CaO2–CcvO2 ratio and
the arterial lactate were at the 24-hour time point. The threshold
for the PcvCO2–PaCO2/CaO2–CcvO2 ratio was 1.696, and that for
lactate was 1.6 mmol/L. The Kaplan–Meier curves at 24 hours
for these thresholds show a significant difference in the survival
probability. This reinforces the general theme that in patients with
sepsis-induced hypotension if resuscitation targets [lactate and the
PcvCO2–PaCO2/CaO2–CcvO2 ratio in this case] are not attained even
after 24 hours of resuscitation, the outcome is poor. Therefore, these
thresholds may be used as resuscitation targets.
The study performed by Ospina-Tascon et al.7 demonstrated
that the prognostic value afforded by lactate was enhanced by the
PcvCO2–PaCO2/CaO2–CcvO2 ratio. The values of AU-ROC for the
lactate and the PcvCO2–PaCO2/CaO2–CcvO2 ratio in our study are
similar, including the sensitivity and specificity. This implies that
the PcvCO2–PaCO2/CaO2–CcvO2 ratio can be reasonably used to
estimate the presence of anaerobic metabolism and predict the
outcome in lieu of the lactate. However, it is noticeable that these
indicators become statistically significant predictors of mortality
only by 24 hours of the onset of hypotension. One can therefore
conclude that hypotension is a relatively early clinical event in
sepsis, while derangements in lactate are a late event.
Although not designed for evaluation of this difference, it is
notable that 73% of patients had an abnormal PcvCO2–PaCO2/
CaO2–CcvO2 ratio, while only 46.67% of patients had abnormal
lactate. At the 24-hour time point, the PcvCO2–PaCO2/CaO2–CcvO2
ratio remained deranged in 78% of patients, while only 61% of
patients had abnormal lactate (>2.0 mmol/L). If one were to look
at lactate alone at the time of enrollment, more than 50% of
patients in our study would not be classified as being in shock. We
feel that it could be further explored whether the PcvCO2–PaCO2/
CaO2–CcvO2 ratio is a more sensitive indicator of tissue hypoxia
than the arterial lactate.
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The patient population in our study was relatively young
(mean age 38.4 years). This is partly because of many patients with
polytrauma being enrolled, which primarily affects the younger
population. The median time between the onset of symptoms and
hospitalization in our study was more than 36 hours. The median
time between hospitalization and recruitment was 97 hours. These
numbers have important implications. A longer time between
symptom/event onset and hospital arrival signifies the possibility
of physiological derangement that has progressed untreated. The
time from hospitalization to recruitment is also long. This meant that
most of the infections that these patients were hospital-acquired,
which have a much higher mortality than community-acquired
infections. It also implies that these episodes of sepsis are potentially
not the first that the patients had. Repeated episodes of sepsis and
septic shock have higher mortality than the first episode. This is an
important distinction between our study and other studies that
enrolled only patients with the first episode of sepsis.
In the present study, the key parameter for enrollment was the
occurrence of hypotension due to sepsis (suspected or proven).
We did not choose any other parameter because hypotension
is the usual clinical marker for intervention, and resuscitation
begins only after the recognition of the clinical marker. Making
the entry criterion clinical would allow more ICUs and centers to
test our hypothesis using the current methodology. We did not
exclude patients based on the first episode of sepsis or the time
since hospitalization. The sole criterion was direct observation
of hypotension and initiation of resuscitation. If a marker of
anaerobic metabolism must perform in clinical practice [the
PcvCO2–PaCO2/CaO2–CcvO2 ratio in this case], it must be validated
across patient categories and severity with minimal exceptions.
We feel this reflects clinical reality, where unselected patients in
the ICU develop hypotension and are resuscitated accordingly. The
quantity of fluids administered in our patients in the first 3 hours
of resuscitation is not in accordance with the surviving sepsis
guidelines (30 mL/kg). The standard protocol in our institution
is not to administer such a large quantity of fluids as a matter
of routine. Our patients spent a considerable amount of time in
the hospital on the general wards/ED before being transferred
to the ICU. This has been alluded to before in this discussion.
Consequently, they invariably receive intravenous crystalloids and
are usually volume replete. This is different from other studies. In
the study by Gustavo-Ospina et al., 8 patients received 1977 mL
(1200–2800 mL) of fluids before the first sampling, which was
3 hours after the first episode of hypotension. In our study, the
interval between the onset of hypotension and the first sample
was a maximum of 1 hour. This is because most of these patients
already had a central venous catheter/intra-arterial catheter
in situ or had these devices inserted almost immediately at the
onset of hypotension. Our approach to hypotension in sepsis is
the simultaneous use of fluids and vasopressors, without waiting
for the completion of fluid boluses. Norepinephrine was the
most common vasopressor used. Dobutamine was used at the
discretion of the treating physician, either aimed at optimizing
ScvO2 or in response to evidence of reduced cardiac contractility
on bedside point-of-care ultrasound (POCUS). This strategy is to
minimize the hypotensive period. The importance of minimizing
the hypotensive duration was shown in a retrospective review
of a large medical database by Maheshwari et al.9 In this study,
hypotension exposure was defined by the time-weighted
average MAP (TW-MAP) and cumulative time below 55, 65, 75,

and 85 mm Hg thresholds. For every one-unit increase in the
TW-MAP <65 mm Hg, the odds of inhospital mortality increased
by 11.4%, the odds of acute kidney injury increased by 7.0%,
and the odds of myocardial injury increased by 4.5%. Sampling
intervals were initially half-hourly till stabilization of the MAP,
for a maximum of 2 hours. This was done to capture the early
changes in PcvCO2–PaCO2/CaCO2–CcvO2 ratio and see if these
changes were reflected by the lactate concentrations. The results
demonstrate that such a correlation does exist. However, there was
no correlation with lactate clearance. We did not use a pulmonary
artery catheter or other direct carbon monoxide monitoring
devices. This is in line with our institutional practice. The study
demonstrates the correlation between two important markers
of tissue hypoxia without measuring CI. In resource-constrained
settings like ours, keeping costs low is also important.
This study did have a few limitations. We used the definition
of sepsis as per the Surviving Sepsis Campaign guidelines, 2012.
The Surviving Sepsis Campaign guidelines 2016 were published
after the finalization of the study design. The use of CO2 partial
pressures instead of contents, as illustrated by Ospina-Tacson
et al., 8 is a potential shortcoming. However, considering the
linearity of the CO2 dissociation curve and the simplicity of using
values from a direct readout of the analyzer, it was felt that the use
of pressures was an acceptable substitute. In an ideal setting, the
cardiac output should have been measured and VO2 calculated. A
correlation between the VO2 and the PcvCO2–PaCO2/CaO2–CcvO2
ratio would be attractive. This is because the ultimate objective
of any resuscitation protocol is to increase the VO2 and reduce
anaerobic metabolism. Bedside POC US and echocardiography,
although freely in use in our ICU, is not part of the written protocol.
Key decisions in the study population (fluid administration and
limitation, determination of the condition of the lung parenchyma,
etc.) were taken using ultrasound. However, since these were
done at the discretion of the treating clinician and performed
in an unselected manner, we could not integrate them into the
study protocol. The details of fluids received in the preceding
24 hours and cumulative fluid balance were not known to the
treating team. This, unfortunately, reflects the reality of practice
in a large public hospital with no electronic monitoring records
and inadequate staffing at the ward/ER level. Such records would
have been invaluable both for the management of the patient and
for the purposes of this study.
In conclusion, the PcvCO2–PaCO2/CaCO2–CcvO2 ratio and the
lactate are positively correlated during the first 24 hours following
active resuscitation from sepsis-induced hypotension. The PcvCO2–
PaCO2/CaCO2–CcvO2 ratio at 24 hours is significantly higher in
nonsurvivors, and a threshold of 1.696 mm Hg/mL/dL for PcvCO2–
PaCO2/CaCO2–CcvO2 ratio at 24 hours significantly differentiates
survivors from nonsurvivors. The PcvCO2-PaCO2 /CaCO2–CcvO2
ratio may be used as an end point of hemodynamic resuscitation
from septic shock.
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